BuzzSparks.org

Avaxia Biologics


Avaxia Biologics (www.avaxiabiologics.com) is a private, early stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease,...

Homepage:
Total money raised: $20.5M

02421 128 Spring Street
Suite 620

Lexington
USA MA

Phone: 781-861-0062

Updated on Sep 5, 2013
Avaxia Biologics at CrunchBase
Barbara S. Fox CEO
David C. Dlesk COO
Christopher Mirabile Investor
Past

June, 2013

Avaxia Biologics raised $11.5M in a Series B round from Cherrystone Angel Group, Golden Seeds, AbbVie, Tech Coast Angels, Beacon Angels, Boston Harbor Angels, LaunchPad Venture Group, Mass Medical Angels, North Country Angels, and Granite State Angels

Avaxia Biologics Completes $11.4M Series B Financing    finsmes.com

March, 2012

Avaxia Biologics raised $1.5M in grant round

Avaxia Biologics Adds $1.5M From Phase II NIH Grant    fis.dowjones.com

February, 2012

Avaxia Biologics raised $4.1M in a Series A round from Cherrystone, Boston Harbor Angels, Beacon Angels, LaunchPad Venture Group, Mass Medical Angels, and North Country Angels

Avaxia Biologics Completes $4.1M Series A Financing    finsmes.com

January, 2012

Avaxia Biologics raised $3.4M in partial round

SEC    sec.gov